The World Professional Association for Transgender Health (WPATH) asserted that cross-sex hormones and surgeries were “medically necessary” so that insurance companies would pay for those procedures, allowing concerns about the treatments’ affordability to dictate claims about their effectiveness, newly unsealed court documents show.
WPATH’s standards of care, which guide clinical practice in the United States, were updated in 2022 to include language about the medical necessity of hormones and surgeries because, as one WPATH official wrote in an email, the group was frustrated with America’s “obtuse and unhealthy system of healthcare ‘coverage.'”
Most private insurance plans and state Medicaid policies exclude procedures deemed elective or cosmetic. That is why, in 2016, WPATH issued a statement describing gender treatments as “medically necessary” and urging U.S. insurers to cover them.
“We needed a tool for our attorneys to use in defending access to care,” a WPATH official recalled in a January 2022 email, one of the many communications unsealed last month during the course of litigation. “The original Medical Necessity Statement was specific to the US because this was where we were experiencing the problem.” […]
– Read More: freebeacon.com
- Gold SKYROCKETED during Trump’s first term and is poised to do it again. Find out how Genesis Precious Metals can help you secure your retirement with a proper self-directed IRA backed by physical precious metals.